Clinical trial
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
NCT00423943 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- December 31, 2012
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizoaffective disorder, schizophrenia